Valuation Takeda Pharmaceutical Company Limited

Equities

4502

JP3463000004

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 02:30:00 2025-07-18 EDT			5-day change	1st Jan Change
4,341.00 ^JPY	-1.61%		-0.85%	+3.83%

07-17	Keros Initiates Dosing in Phase 3 Anemia Trial, Triggering $10 Million Milestone Payment From Takeda	MT
07-14	Sector Update: Health Care Stocks Decline Premarket Monday	MT

Company Valuation: Takeda Pharmaceutical Company Limited

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	6,229,971	5,423,454	6,762,204	6,564,378	6,749,675	6,854,912	-	-
Change	-	-12.95%	24.68%	-2.93%	2.82%	1.56%	-	-
Enterprise Value (EV) ¹	9,862,522	8,919,170	10,611,015	10,950,330	10,725,175	10,668,599	10,402,267	10,164,447
Change	-	-9.57%	18.97%	3.2%	-2.06%	-0.53%	-2.5%	-2.29%
P/E ratio	16.6x	23.8x	21.3x	45.4x	64.6x	27.9x	23.1x	19.9x
PBR	1.2x	0.95x	1.06x	0.9x	1x	1x	1x	0.99x
PEG	-	-0.6x	0.5x	-0.8x	-2.5x	0x	1.1x	1.2x
Capitalization / Revenue	1.95x	1.52x	1.68x	1.54x	1.47x	1.5x	1.49x	1.46x
EV / Revenue	3.08x	2.5x	2.63x	2.57x	2.34x	2.33x	2.26x	2.17x
EV / EBITDA	9.23x	8.54x	9.19x	11.6x	9.71x	8.59x	8.32x	7.87x
EV / EBIT	19.4x	19.4x	21.6x	51.1x	31.3x	21.7x	18.3x	16.4x
EV / FCF	16x	8.92x	28.7x	43.4x	15.5x	13.5x	14.9x	13.8x
FCF Yield	6.26%	11.2%	3.49%	2.31%	6.43%	7.4%	6.7%	7.22%
Dividend per Share ²	180	180	180	188	196	200	203.9	210.2
Rate of return	4.52%	5.15%	4.14%	4.49%	4.44%	4.61%	4.7%	4.84%
EPS ²	240.7	147.1	204.3	92.09	68.36	155.5	187.9	218.2
Distribution rate	74.8%	122%	88.1%	204%	287%	129%	109%	96.4%
Net sales ¹	3,197,812	3,569,006	4,027,478	4,263,762	4,581,600	4,578,736	4,594,195	4,691,475
EBITDA ¹	1,068,940	1,043,995	1,154,905	942,077	1,103,982	1,241,361	1,250,170	1,290,828
EBIT ¹	509,269	460,844	490,505	214,100	342,600	492,020	567,498	618,174
Net income ¹	376,005	230,059	317,017	144,067	107,900	242,823	299,455	335,894
Net Debt ¹	3,632,551	3,495,716	3,848,811	4,385,952	3,975,500	3,813,687	3,547,355	3,309,535
Reference price ²	3,985.00	3,498.00	4,350.00	4,184.00	4,413.00	4,341.00	4,341.00	4,341.00
Nbr of stocks (in thousands)	1,563,355	1,550,444	1,554,530	1,568,924	1,529,498	1,579,109	-	-
Announcement Date	5/11/21	5/11/22	5/11/23	5/9/24	5/8/25	-	-	-

¹JPY in Million²JPY

Estimates

P/E ratio, Detailed evolution

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
TAKEDA PHARMACEUTICAL COMPANY LIMITED	27.92x	2.33x	8.59x	4.61%	46.18B
ELI LILLY AND COMPANY	36.13x	11.98x	27.23x	0.77%	693B
JOHNSON & JOHNSON	14.63x	4.31x	11.78x	3.15%	394B
ABBVIE INC.	27.14x	6.49x	13.73x	3.45%	334B
NOVO NORDISK A/S	15.94x	5.78x	11.57x	3.18%	287B
ROCHE HOLDING AG	14.37x	3.52x	8.72x	3.82%	259B
NOVARTIS AG	16.56x	4.4x	10.31x	3.49%	223B
ASTRAZENECA PLC	21.78x	4.08x	12x	2.32%	215B
MERCK & CO., INC.	10.26x	3.33x	7.2x	4.02%	201B
AMGEN INC.	22.54x	5.77x	11.13x	3.25%	158B
Average	20.73x	5.20x	12.23x	3.21%	281.11B
Weighted average by Cap.	22.58x	6.51x	15.00x	2.72%